Funding
We offer various funding opportunities to members, MSK experts and trainees, to support innovation and interdisciplinary research in musculoskeletal health.
BJI members
BJI Catalyst Grants Program
The BJI catalyst grant competition is designed to support interdisciplinary early-stage projects by awarding members up to $130,000 each year in seed funding.
BJI Strategic Fund Program
This program provides BJI members with flexible and timely support for interdisciplinary, transformative research in line with BJI’s strategic priorities.
MSK experts
MSK Innovation Competition
Held in partnership with the Morrissette Institute for Entrepreneurship, the MSK Innovation Competition is open to all London-based entrepreneurial MSK experts who’d like to pitch innovative ideas with commercial potential.
Trainees
BJI Transdisciplinary Awards
The purpose of our transdisciplinary award program is to foster the next generation of MSK researchers and promote an environment of interdisciplinary collaboration.
Western graduate students, postdocs, and clinical scientists interested in interdisciplinary MSK research across all areas of musculoskeletal health are welcome to apply*.
*Please read our eligibility criteria carefully.
BJI Undergraduate Summer Research Program
This program is a great opportunity for Western undergraduate students to further their MSK-related research, work in an interdisciplinary environment, gain technical expertise, and connect with mentors and a network of interdisciplinary researchers.
Meet some of our previous award winners
MSK Innovation Competition winners aim to increase amputees’ comfort, quality of life
Vessl Prosthetics founders Oleksiy Zaika, Sydney Robinson met through Medical Innovation Fellowship program.
Catalyst Grant winner brings X-ray technology to developing countries
BJI member David Holdsworth and a team of African and Canadian medical imaging experts are in the process of developing a cost-effective, portable digital x-ray system.
MSK Innovation Competition winners are using technology to revolutionize primary care
Two companies are set to make revolutionary impacts on diagnosing musculoskeletal (MSK) diseases, resulting in better and more accessible care.
